Gene: TTC38
Official Full Name: tetratricopeptide repeat domain 38provided by HGNC
Gene Summary: Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12951 | TTC38 Knockout cell line (HeLa) | Human | TTC38 | 1:3~1:6 | Negative | Online Inquiry |
KO12952 | TTC38 Knockout cell line (HCT 116) | Human | TTC38 | 1:2~1:4 | Negative | Online Inquiry |
KO12953 | TTC38 Knockout cell line (HEK293) | Human | TTC38 | 1:3~1:6 | Negative | Online Inquiry |
KO12954 | TTC38 Knockout cell line (A549) | Human | TTC38 | 1:3~1:4 | Negative | Online Inquiry |
TTC38 Gene Knockout Cell Lines are highly specialized biological tools designed for advanced genetic research and functional studies. These cell lines have been generated using state-of-the-art CRISPR-Cas9 technology to disrupt the TTC38 gene, a key player in various cellular processes including autophagy and protein secretion. By precisely knocking out this gene, researchers can investigate the specific functional roles of TTC38 in cellular mechanisms, making it invaluable for studies related to disease models, particularly in the context of neurodegeneration and metabolic disorders.
The functionality of TTC38 Gene Knockout Cell Lines is rooted in their ability to mimic pathological states, aiding scientists in elucidating the consequences of genetic disruptions on cellular behavior. This allows for the detailed investigation of signaling pathways and the assessment of potential therapeutic interventions. Moreover, these cell lines provide a robust platform for high-throughput screening of drugs, facilitating the identification of compounds that can modulate the activity of related pathways.
The scientific importance of these cell lines extends into both research and clinical applications. In laboratory settings, they foster a deeper understanding of gene function and interactions in human cells, which is essential for translational research endeavors. Clinically, they can assist in developing targeted therapies, particularly for conditions linked to the dysregulation of the TTC38 gene.
One of the standout advantages of the TTC38 Gene Knockout Cell Lines is their unparalleled specificity and fidelity in gene editing compared to traditional methods such as siRNA or antisense oligonucleotides, which may not yield complete knockouts. Additionally, our cell lines are generated under stringent quality control, ensuring high viability and reproducibility across experiments, thus providing researchers with a reliable resource for their studies.
Researchers and clinicians will find TTC38 Gene Knockout Cell Lines indispensable for advancing their work in gene function elucidation and therapeutic development. The ability to disrupt specific genes with precision enhances experimental reliability, accelerates discovery timelines, and ultimately contributes to novel insights and treatments.
As a company dedicated to supporting scientific innovation, we pride ourselves on our expertise in generating high-quality biological products tailored to meet the needs of researchers and clinicians alike. Our commitment to advancing life sciences ensures that we provide invaluable resources, such as TTC38 Gene Knockout Cell Lines, that facilitate groundbreaking discoveries and advancements in the field.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.